Olga Ignatyeva

1.3k total citations · 1 hit paper
18 papers, 782 citations indexed

About

Olga Ignatyeva is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Olga Ignatyeva has authored 18 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 13 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Olga Ignatyeva's work include Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (9 papers) and Pneumonia and Respiratory Infections (8 papers). Olga Ignatyeva is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (9 papers) and Pneumonia and Respiratory Infections (8 papers). Olga Ignatyeva collaborates with scholars based in Russia, United Kingdom and Germany. Olga Ignatyeva's co-authors include Vladyslav Nikolayevskyy, Yanina Balabanova, Francis Drobniewski, Irina Kontsevaya, Nicola Casali, Sergey Nejentsev, Rolf D. Horstmann, Timothy J. Brown, Julian Parkhill and Simon R. Harris and has published in prestigious journals such as Nature Genetics, PLoS ONE and Genome Research.

In The Last Decade

Olga Ignatyeva

17 papers receiving 765 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolution and transmission of drug-resistant tuberculosis in a Russian population

2014 350 citations Nicola Casali, Vladyslav Nikolayevskyy et al. Nature Genetics profile →

Peers

Countries citing papers authored by Olga Ignatyeva

Since Specialization

Citations

This map shows the geographic impact of Olga Ignatyeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Ignatyeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Ignatyeva more than expected).

Fields of papers citing papers by Olga Ignatyeva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Ignatyeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Ignatyeva. The network helps show where Olga Ignatyeva may publish in the future.

Co-authorship network of co-authors of Olga Ignatyeva

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Ignatyeva. A scholar is included among the top collaborators of Olga Ignatyeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Ignatyeva. Olga Ignatyeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Christensenella minuta, a new candidate next-generation probiotic: current evidence and future trajectories 2024 ·Frontiers in Microbiology ·Olga Ignatyeva, (unknown), (unknown), (unknown), (unknown), Д. А. Каштанова, (unknown), (unknown), V. S. Yudin, В. В. Макаров, Anton А. Keskinov, (unknown), S. M. Yudin	19
2	Diagnosis and Treatment of Vertebrobasilar Insufficiency and Pain Syndrome in Patients with Kimmerle anomaly 2024 ·Bulletin of Science and Practice ·(unknown), А. Л. Калинкин, (unknown), (unknown), (unknown), Olga Ignatyeva, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
3	GWAS reveals genetic basis of a predisposition to severe COVID-19 through in silico modeling of the FYCO1 protein 2023 ·Frontiers in Medicine ·(unknown), (unknown), Д. А. Каштанова, (unknown), (unknown), (unknown), (unknown), Olga Ignatyeva, (unknown), (unknown), (unknown), V. S. Yudin, В. В. Макаров, Anton А. Keskinov, S. M. Yudin	2
4	Diagnostic and prognostic value of biomarkers in atopic dermatitis for assessing its endotypes, phenotypes, and treatment efficacy 2023 ·Russian Journal of Allergy ·O G Elisyutina, E S Fedenko, (unknown), Olga Ignatyeva, Musa Khaitov	0
5	Biomarkers of Treatment Success in Fully Sensitive Pulmonary Tuberculosis Patients: A Multicenter Longitudinal Study 2020 ·Biomarkers in Medicine ·Vladyslav Nikolayevskyy, Yanina Balabanova, Irina Kontsevaya, Olga Ignatyeva, Ģirts Šķenders, (unknown), David van Bockel, Francis Drobniewski	2
6	Tuberculosis cases caused by heterogeneous infection in Eastern Europe and their influence on outcomes 2016 ·Infection Genetics and Evolution ·Irina Kontsevaya, Vladyslav Nikolayevskyy, (unknown), Olga Ignatyeva, (unknown), (unknown), (unknown), (unknown), (unknown), Edita Davidavičienė, Girts Skenders, (unknown), Yanina Balabanova, Francis Drobniewski	12
7	Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference? 2016 ·Thorax ·Yanina Balabanova, Olga Ignatyeva, Lena Fiebig, Vija Riekstiņa, Manfred Danilovitš, (unknown), Edita Davidavičienė, (unknown), (unknown), Vladyslav Nikolayevskyy, Francis Drobniewski	23
8	Resistance profile and risk factors of drug resistant tuberculosis in the Baltic countries 2015 ·Tuberculosis ·Olga Ignatyeva, Yanina Balabanova, Vladyslav Nikolayevskyy, (unknown), (unknown), Edita Davidavičienė, Vija Riekstiņa, (unknown), Manfred Danilovitš, (unknown), Francis Drobniewski	19
9	Beijing clades of Mycobacterium tuberculosis are associated with differential survival in HIV-negative Russian patients 2015 ·Infection Genetics and Evolution ·Yanina Balabanova, Vladyslav Nikolayevskyy, Olga Ignatyeva, Irina Kontsevaya, (unknown), (unknown), (unknown), (unknown), Ivan Fedorin, Nicola Casali, Richard Hooper, Rolf D. Horstmann, Sergey Nejentsev, Sven Hoffner, Peter Nüernberg, Francis Drobniewski	6
10	Evolution and transmission of drug-resistant tuberculosis in a Russian population breakdown → 2014 ·Nature Genetics ·Nicola Casali, Vladyslav Nikolayevskyy, Yanina Balabanova, Simon R. Harris, Olga Ignatyeva, Irina Kontsevaya, Jukka Corander, Josephine M. Bryant, Julian Parkhill, Sergey Nejentsev, Rolf D. Horstmann, Timothy J. Brown, Francis Drobniewski	350
11	Utility of propidium monoazide viability assay as a biomarker for a tuberculosis disease 2014 ·Tuberculosis ·Vladyslav Nikolayevskyy, Paolo Miotto, (unknown), Yanina Balabanova, Irina Kontsevaya, Olga Ignatyeva, Alessandro Ambrosi, Girts Skenders, Arvydas Ambrozaitis, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Daniela María Cirillo, Francis Drobniewski	23
12	Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation 2013 ·BMC Medicine ·Francis Drobniewski, Vladyslav Nikolayevskyy, (unknown), Yanina Balabanova, Nicola Casali, Irina Kontsevaya, Olga Ignatyeva	52
13	Diagnostic Accuracy of the GenoType MTBDR sl Assay for Rapid Diagnosis of Extensively Drug-Resistant Tuberculosis in HIV-Coinfected Patients 2012 ·Journal of Clinical Microbiology ·Irina Kontsevaya, Olga Ignatyeva, Vladyslav Nikolayevskyy, Yanina Balabanova, (unknown), (unknown), (unknown), Francis Drobniewski	18
14	Microevolution of extensively drug-resistant tuberculosis in Russia 2012 ·Genome Research ·Nicola Casali, Vladyslav Nikolayevskyy, Yanina Balabanova, Olga Ignatyeva, Irina Kontsevaya, Simon R. Harris, Stephen D. Bentley, Julian Parkhill, Sergey Nejentsev, Sven Hoffner, Rolf D. Horstmann, Timothy J. Brown, Francis Drobniewski	141
15	Detection of Resistance to Second-Line Antituberculosis Drugs by Use of the Genotype MTBDR sl Assay: a Multicenter Evaluation and Feasibility Study 2012 ·Journal of Clinical Microbiology ·Olga Ignatyeva, Irina Kontsevaya, (unknown), Yanina Balabanova, Vladyslav Nikolayevskyy, Kadri Toit, (unknown), (unknown), (unknown), Tiina Kummik, (unknown), (unknown), Francis Drobniewski	37
16	Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study 2011 ·BMJ Open ·Yanina Balabanova, (unknown), Edita Davidavičienė, Richard Hooper, Olga Ignatyeva, Vladyslav Nikolayevskyy, F. Drobniewski	35
17	Survival of Civilian and Prisoner Drug-Sensitive, Multi- and Extensive Drug- Resistant Tuberculosis Cohorts Prospectively Followed in Russia 2011 ·PLoS ONE ·Yanina Balabanova, Vladyslav Nikolayevskyy, Olga Ignatyeva, Irina Kontsevaya, Clare Rutterford, (unknown), (unknown), (unknown), (unknown), Ivan Fedorin, Francis Drobniewski	26
18	Association analysis of the LTA4H gene polymorphisms and pulmonary tuberculosis in 9115 subjects 2010 ·Tuberculosis ·James Curtis, (unknown), (unknown), (unknown), Olga Ignatyeva, Yanina Balabanova, Vladyslav Nikolayevskyy, Sven Hoffner, Rolf D. Horstmann, Francis Drobniewski, Sergey Nejentsev	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact